The Lancet with special edition
The Global Burden of Disease Study (GBD) is the most comprehensive worldwide observational epidemiological study to date. It describes mortality and morbidity from major diseases, injuries and risk factors to health at global, national and regional levels. Examining trends from 1990 to the present and making comparisons across populations enables understanding of the changing health challenges facing people across the world in the 21st century.
The GBD 2015 update, with new data from 1990 to 2015, provides a detailed overview of the diseases and injuries of which we die or live with, and which causes health loss to varying degrees. In addition, the GBD project calculates mortality and morbidity from important risk factors. New data will now be available for 195 countries and territories.
The Centre for Disease Burden at the Norwegian Institute of Public Health cooperates closely with the international project coordinated by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle. The centre contributes data and evaluates Norwegian data sources and results.
"The total disease burden in a country is a combination of how many people are affected by various diseases, the severity of the diseases for those affected and whether they lead us to die prematurely," says professor Stein Emil Vollset, head of the Centre for Disease Burden, NIPH.
Vollset and other staff at the center are co-authors of the Lancet articles. The centre will sum up the new Norwegian results from GBD 2015 later.
For the first time, GBD's interactive graphs, maps and tools are also translated into Norwegian.
More than 1,800 partners in 130 countries contribute to the GBD project. GBD is the largest and most comprehensive study of human health worldwide.